Endovascular Therapy in Mild Ischemic Strokes Presenting Under 6 hours: An International Survey
Introduction
Endovascular therapy (EVT) has revolutionized treatment of patients with moderate to severe ischemic stroke and concurrent occlusion, but patients with mild ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] ≤5) were either excluded,1, 2, 3, 4–5 or markedly underrepresented in large randomized controlled trials.6, 7–8 The role of EVT in patients with mild symptoms and a visible intracranial occlusion (in the large or medium vessels) is unknown.
About 14% of patients with mild ischemic stroke present with visible intracranial occlusion, and despite seemingly benign initial presentations, up to one third of these patients suffer significant disability and death within 90 day follow up.9, 10–11 The safety of EVT in mild stroke is largely unknown though several retrospective studies have reported the use of EVT in mild stroke worldwide.12–14 Despite these analyses suggesting possible benefit of EVT in mild stroke, there are no randomized clinical trials to support these observations. Correspondingly, the American Heart Association/American Stroke Association gives a Class II, Level of Evidence B recommendation for EVT in patients with a NIHSS <6, presenting within 6 hours of symptom onset or last known well, and a causative occlusion of the internal carotid artery (ICA), proximal MCA (M1), or M2/M3 segment.15
In routine clinical practice, physicians need to make complex decisions regarding patient selection for advanced imaging and reperfusion in those presenting with mild neurological symptoms and concurrent vessel occlusion. The lack of data from clinical trials in this population translate into uncertainties regarding appropriate acute therapies and wide practice variability amongst physicians. Furthermore, evidence is limited regarding which non-clinical factors influence physician decision to pursue advanced imaging and/or endovascular therapy in patients with mild stroke.
The present survey aims to study global variations in clinical practice regarding immediate decisions for obtaining advanced imaging and offering EVT to patients with mild stroke and concurrent vessel occlusion.
Section snippets
Methods
All data from this study is available from the corresponding author upon request.
Results
Between April 4, 2019 and June 30, 2019, the survey link was sent to various professional listservs with estimated distribution list of over 4,000 across the globe. Among these, 492 opened the survey link and 482 had analyzable data, consisting of at least one out of the six cases. A total of 2406 responses were available for analysis. A summary of clinical case scenarios and treatment decisions can be found in Table 1.
The mean age of responders was 45.1 (± 9.1) years and 22.7% were women. The
Discussion
This international survey evaluated current practice patterns of offering endovascular therapy to patients with mild ischemic symptoms and relevant intracranial occlusion. Attending physicians and older practitioners were more likely to request advanced imaging prior to making a final decision, and younger age and fellow responders were more likely to offer EVT. Geographic location of practice also significantly affected therapeutic decisions. As compared to responders in Australia and USA,
Conclusions
In summary, this study highlights global variability in use of advanced imaging and pursuit of endovascular therapy for mild stroke patients with intracranial occlusion. Further research is crucial to improve the evidence base for this important subset of stroke patients and to inform clinical guidelines.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
Study data were collected and managed using REDCap electronic data capture tools hosted at University of Miami.
References (23)
- et al.
Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (thrace): a randomised controlled trial
Lancet Neurol
(2016) - et al.
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
Lancet
(2016) - et al.
Research electronic data capture (redcap) – a metadata-driven methodology and workflow process for providing translational research informatics support
J Biomed Inform
(2009) - et al.
Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct
N Engl J Med
(2018) - et al.
Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging
N Engl J Med
(2018) - et al.
Stent-retriever thrombectomy after intravenous t-pa vs. T-pa alone in stroke
N Engl J Med
(2015) - et al.
Thrombectomy within 8 hours after symptom onset in ischemic stroke
N Engl J Med
(2015) - et al.
A randomized trial of intraarterial treatment for acute ischemic stroke
N Engl J Med
(2015) - et al.
Endovascular therapy for ischemic stroke with perfusion-imaging selection
N Engl J Med
(2015) - et al.
The high risk of stroke immediately after transient ischemic attack: a population-based study
Neurology
(2004)
Outcome of stroke with mild or rapidly improving symptoms
Stroke
Cited by (3)
Hot topics of endovascular therapy for acute ischemic stroke
2021, Chinese Journal of Cerebrovascular Diseases
- 1
These authors contributed equally to this work.